FIELD: medicine.
SUBSTANCE: blood leukocyte level, erythrocyte sedimentation rate, blood fibrinogen level are measured. A prognostic index is calculated by formula Z=0.217×X1+0.083×X2+0.458×X3, where X1 is leukocytes - L (109/l), X2 is erythrocyte sedimentation rate - ESR (mm/h), X3 - venous blood fibrinogen - FG (g/l). If the Z value is less than 6.96, non-necrosis uterine myoma is predicted; if the Z value exceeds 7.80, uterine myoma necrosis is predicted, and the Z value within the range 6.96 to 7.80 provides uncertainty and requires progression follow-up of a patient.
EFFECT: use of the method allows predicting tumour necrosis that is an additional criterion to build indications for surgical management in pregnancy.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING MORPHOLOGICAL TYPES OF UTERINE LEIOMYOMA | 2009 |
|
RU2400757C1 |
| METHOD OF PREDICTING FAST GROWTH OF HYSTEROMYOMA | 2007 |
|
RU2350259C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704817C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATING UTERINE FIBROIDS USING FUS-MRI ABLATION IN THE PATIENTS OF REPRODUCTIVE AGE AT THE STAGE OF PREGNANCY PLANNING | 2019 |
|
RU2716337C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
| METHOD FOR PREDICTING GROWTH RATE OF UTERINE LEIOMYOMA IN WOMEN OF REPRODUCTIVE AGE | 2018 |
|
RU2690379C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
| DIAGNOSTIC TECHNIQUE FOR DETERMINING PROBABILITY OF LOCAL INFLAMMATION DEVELOPMENT IN MYOMATOUS NODULE | 2014 |
|
RU2592242C2 |
| METHOD FOR PREDICTION OF PRIMARY HYPOTHONIC UTERINE DYSFUNCTION IN PRIMIPARA WOMEN | 2015 |
|
RU2623037C2 |
